TrialBritish journal of cancer2015

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.

A J Weickhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.